COVID-19患者的神经影像学:神经放射学专家组共识
欧洲神经放射学会(ESNR)诊断神经放射学亚专科委员会组建NeuroCovid工作组,针对COVID-19神经系统表现患者的神经影像学检查指征、MRI采集方案及随访必要性提出标准化建议。共识基于专家意见,旨在提高患者诊疗质量并为未来临床研究提供高质量影像保障。
要点
- COVID-19伴神经系统表现患者应行神经影像学检查以检出潜在致病病理。
- 推荐基础MRI方案包括T2WI、FLAIR(优选3D)、DWI、出血敏感序列(优选SWI)及初始检查至少平扫与增强T1WI。
- 增强后应采集3D FLAIR以优化软脑膜强化检出。
核心结论
- COVID-19伴神经系统表现患者应行神经影像学检查以检出潜在致病病理;工作组基于专家意见提出标准化MRI采集方案,旨在改善患者诊疗质量并确保未来临床研究的高质量。
研究设计与样本
- 欧洲神经放射学会(ESNR)诊断神经放射学亚专科委员会组建NeuroCovid工作组,由COVID-19神经影像领域专家构成,以专家意见为基础提出建议。
诊断标准与关键数值
- 推荐基础MRI方案包括T2加权、FLAIR(优选3D)及扩散加权成像,以及出血敏感序列(优选SWI)。
- 至少初始检查应包括平扫与增强T1加权成像。
- 增强后应采集3D FLAIR以优化软脑膜对比增强的检出。
临床应用与阅片要点
- 对COVID-19伴神经系统表现患者,应按共识推荐行神经影像学检查以检出潜在致病病理。
- 基础MRI方案应包含T2加权、FLAIR(优选3D)、扩散加权成像及出血敏感序列(优选SWI)。
- 初始检查至少应包含平扫与增强T1加权成像;增强后采集3D FLAIR以优化软脑膜强化检出。
局限性
- 现有影像数据非常异质。
- 建议基于专家意见。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Neurological and neuroradiological manifestations in patients with COVID-19 have been extensively reported. Available imaging data are, however, very heterogeneous. Hence, there is a growing need to standardise clinical indications for neuroimaging, MRI acquisition protocols, and necessity of follow-up examinations. A NeuroCovid working group with experts in the field of neuroimaging in COVID-19 has been constituted under the aegis of the Subspecialty Committee on Diagnostic Neuroradiology of the European Society of Neuroradiology (ESNR). The initial objectives of this NeuroCovid working group are to address the standardisation of the imaging in patients with neurological manifestations of COVID-19 and to give advice based on expert opinion with the aim of improving the quality of patient care and ensure high quality of any future clinical studies. KEY POINTS: • In patients with COVID-19 and neurological manifestations, neuroimaging should be performed in order to detect underlying causal pathology. • The basic MRI recommended protocol includes T2-weighted, FLAIR (preferably 3D), and diffusion-weighted images, as well as haemorrhage-sensitive sequence (preferably SWI), and at least for the initial investigation pre and post-contrast T1 weighted-images. • 3D FLAIR should be acquired after gadolinium administration in order to optimise the detection of leptomeningeal contrast enhancement.
引用
- Kremer, Gerevini, Ramos, et al. Neuroimaging in patients with COVID-19: a neuroradiology expert group consensus. Eur Radiol. 2022. PMID: 35044509. doi:10.1007/s00330-021-08499-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。